Skip to main content
. Author manuscript; available in PMC: 2014 Jul 21.
Published in final edited form as: Cancer Biol Ther. 2007 Oct 19;7(1):135–144. doi: 10.4161/cbt.7.1.5199

Figure 3.

Figure 3

Global ASE distribution in control and pancreatic cancer samples. A genomic ASE genome index may be estimated as the fraction of heterozygotes displaying ASE (Y-axis represents the percentage of SNPs normalized within control and pancreatic cancer samples). The global distribution of this genomic index is not statistically significant (p < 0.15) between CEPH and NFPTR samples, although there is a trend towards lower ASE levels in the pancreatic cancer germline.